BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30107644)

  • 1. Genomic landscape and mutational impacts of recurrently mutated genes in cancers.
    Liu B; Hu FF; Zhang Q; Hu H; Ye Z; Tang Q; Guo AY
    Mol Genet Genomic Med; 2018 Nov; 6(6):910-923. PubMed ID: 30107644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
    Jonckheere N; Van Seuningen I
    J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
    Li X
    Cancer Med; 2016 Jul; 5(7):1556-65. PubMed ID: 26992457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers.
    Ye Z; Zhang H; Kong F; Lan J; Yi S; Jia W; Zheng S; Guo Y; Zhan X
    Oxid Med Cell Longev; 2021; 2021():9259297. PubMed ID: 34970420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape and significance across 12 major cancer types.
    Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
    Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of candidate radio marker genes using a coexpression network analysis in gamma-irradiated rice.
    Kim SH; Hwang SG; Hwang JE; Jang CS; Velusamy V; Kim JB; Kim SH; Ha BK; Kang SY; Kim DS
    Physiol Plant; 2013 Dec; 149(4):554-70. PubMed ID: 23617399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
    Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
    Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Identification of RNA Modification Gene
    Li H; Chen L; Han Y; Zhang F; Wang Y; Han Y; Wang Y; Wang Q; Guo X
    Biology (Basel); 2021 Nov; 10(11):. PubMed ID: 34827123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cancer profiling of molecular alterations within the human autophagy interaction network.
    Lebovitz CB; Robertson AG; Goya R; Jones SJ; Morin RD; Marra MA; Gorski SM
    Autophagy; 2015; 11(9):1668-87. PubMed ID: 26208877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets.
    Zhang Y; Huang W; Chen D; Zhao Y; Sun F; Wang Z; Lou G
    Front Genet; 2022; 13():823082. PubMed ID: 35754835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing genomic differences of human cancer stratified by the TP53 mutation status.
    Wang M; Yang C; Zhang X; Li X
    Mol Genet Genomics; 2018 Jun; 293(3):737-746. PubMed ID: 29330617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared and unique mutational gene co-occurrences in cancers.
    Liu J; Zhao D; Fan R
    Biochem Biophys Res Commun; 2015 Oct; 465(4):777-83. PubMed ID: 26315265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
    Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
    BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.